Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Astronaut: SGLT2i on Renal Oxygenation in T1D
NCT04193566Phase 4Completed
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Feb 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in diabetic nephropathy (DN), sponsored by Steno Diabetes Center Copenhagen. Started Feb 2020; status: completed.
02
Drugs
dapagliflozin
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT04193566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04193566.